Q1 claimed the highest number of trial starts in 2022
AbbVie knocks down earnings forecast due to IPR&D charge
FDA forces unproven premature birth drug Makena off market
Is the pharma industry particularly vulnerable to inflation?
*please scroll down for all the latest news*
